Business Context and Reporting Period
Allarity Therapeutics, Inc. (Nasdaq: ALLR), an emerging growth company, filed this Form 8-K on May 27, 2026. The report discloses the execution of an Amended and Restated Management Services Agreement (A&R MSA) with Ljungaskog Consulting AB, owned and managed by CEO Thomas H. Jensen, effective June 1, 2026.
Key Financial Metrics
This filing does not contain standard financial statements, revenue, profit, cash flow, or debt metrics. The only financial data disclosed relates to executive compensation under the new agreement:
- 2026 Annual Base Salary: SEK 6,000,000 (80%) and US$163,043 (20%).
- Signing Bonus: Eliminated (previously $100,000 under the original agreement).
- Annual Bonus Cap: 60% of the Monthly Fees paid in a calendar year.
- Termination Payment (Company Convenience): 12 months of the Monthly Fee.
Material Changes Versus Prior Period
The A&R MSA replaces the Original MSA entered into on June 1, 2024. Key changes include:
- Compensation Structure: Removal of the one-time $100,000 signing bonus. Introduction of a split currency payment structure for the base salary.
- Termination Notice (Company): Increased from 15 days to 30 days.
- Severance (Company Convenience): Added a "Termination Payment" of 12 months of fees (previously only accrued payments were due).
- Severance (Good Reason): Increased from 9 months of fees to 12 months of fees.
- Regulatory Compliance: Added provisions addressing Internal Revenue Code Sections 409A and 280G.
Guidance, Outlook, and Risks
The filing contains no financial guidance, outlook, or general risk factors. The primary contingency noted is the requirement for the Consultant to execute a general release of claims and cooperate with transition matters to receive termination payments. The agreement also includes specific tax compliance provisions if the Consultant is subject to U.S. federal income taxation.
Investor Verification Checklist
- Verify the full text of the Amended and Restated Management Services Agreement (Exhibit 10.1) for complete terms.
- Confirm the impact of the increased termination liability (12 months of fees) on the company's cash reserves.
- Monitor the issuance of new annual bonus performance metrics by March 31, 2027, to determine if prior year metrics apply.
- Review the currency exchange risk associated with the 80% SEK salary component.